Effect of using Mobile Messenger for Insulin Injection Education for Glycemic Control: A Randomized Controlled Trial.

• Authors : Yingyaun, Kannikar; Charoensri, Suranut; Pongchaiyakul, Chatlert

• Source: Pacific Rim International Journal of Nursing Research (PAC RIM INT J NURS RES), Jul-Sep2022; 26(3): 461-473. (13p)

Record details

Single Nucleotide Polymorphism in the ADIPOQ Gene Modifies Adiponectin Levels and Glycemic Control in Type Two Diabetes Mellitus Patients.

• Authors : Alfaqih, Mahmoud A.; Al-hawamdeh, Aisha; Amarin, Zouhair O.

• Source: BioMed Research International (BIOMED RES INT), 4/27/2022; 1-10. (10p)

Record details

Living and working environments are important determinants of glycemic control in patients with diabetes during the COVID-19 pandemic: A retrospective observational study.

• Authors : Terakawa A; Department of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo, Japan.; Bouchi R

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/epidemiology ; Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/therapy

• Source: Journal of diabetes investigation [J Diabetes Investig] 2022 Jun; Vol. 13 (6), pp. 1094-1104. Date of Electronic Publication: 2022 Feb 16.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

Association Between Social Vulnerability and Achieving Glycemic Control Among Pregnant Individuals With Pregestational Diabetes.

• Authors : Venkatesh KK; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, the College of Medicine, the Division of Endocrinology, Department of Medicine, and the Department of Bioinformatics, The Ohio State University, Columbus, Ohio.; Germann K

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/therapy ; Glycemic Control*

• Source: Obstetrics and gynecology [Obstet Gynecol] 2022 Jun 01; Vol. 139 (6), pp. 1051-1060. Date of Electronic Publication: 2022 May 02.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401101 Publication Model: Print-Electronic Cited Medium:

Record details

Practical approach to clinical controversies in glycemic control for hospitalized surgical patients.

• Authors : Ware LR; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Gilmore JF

Subjects: Glycemic Control* ; Hyperglycemia*/Hyperglycemia*/Hyperglycemia*/etiology ; Hyperglycemia*/Hyperglycemia*/Hyperglycemia*/prevention & control

• Source: Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition [Nutr Clin Pract] 2022 Jun; Vol. 37 (3), pp. 521-535. Date of Publisher: Wiley Country of Publication: United States NLM ID: 8606733 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-2452

Record details

Effect of Nigella Sativa Oil on Oxidative Stress, Inflammatory, and Glycemic Control Indices in Diabetic Hemodialysis Patients: A Randomized Double-Blind, Controlled Trial.

• Authors : Rahmani, Alireza; Niknafs, Bahram; Naseri, Mohsen

• Source: Evidence-based Complementary & Alternative Medicine (eCAM) (EVID BASED COMPLEMENT ALTERN MED), 4/15/2022; 1-9. (9p)

Record details

The effects of butyrate supplementation on glycemic control, lipid profile, blood pressure, nitric oxide level and glutathione peroxidase activity in type 2 diabetic patients: A randomized triple -blind, placebo-controlled trial.

• Authors : Khosravi Z; Student Research Committee, Nutrition Research Center, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glycemic Control*; Antioxidants/Antioxidants/Antioxidants/therapeutic use

• Source: Clinical nutrition ESPEN [Clin Nutr ESPEN] 2022 Jun; Vol. 49, pp. 79-85. Date of Electronic Publication: 2022 Mar 15.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101654592 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Reply to Scaramuzza et al.: Comment on "Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes" by Messer et al.

• Authors : Messer LH; Barbara Davis Center, University of Colorado School of Medicine, Aurora, Colorado, USA.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Glycemic Control*; Adolescent

• Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Jun; Vol. 24 (6), pp. 458-459.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Comparison of the effects of Tai Chi and general aerobic exercise on weight, blood pressure and glycemic control among older persons with depressive symptoms: a randomized trial.

• Authors : Wang Y; Department of Nursing, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Sichuan University, Chengdu, 610041, China.

Subjects: Blood Pressure* ; Body Weight* ; Depression*/Depression*/Depression*/therapy

• Source: BMC geriatrics [BMC Geriatr] 2022 May 07; Vol. 22 (1), pp. 401. Date of Electronic Publication: 2022 May 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100968548 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2318

Record details

Association between Glycemic Control and Drug Therapy Concordance in Individuals with Type 2 Diabetes Mellitus: A Cross-sectional Study.

• Authors : Jha S; Sr. Director & HOD, Max Healthcare, New Delhi.; Verma MK

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glycemic Control*; Blood Glucose

• Source: The Journal of the Association of Physicians of India [J Assoc Physicians India] 2022 May; Vol. 70 (5), pp. 11-12.Publisher: Association of Physicians of India Country of Publication: India NLM ID: 7505585 Publication Model: Print Cited Medium: Print ISSN:

Record details